Oxidative stress and antioxidant therapy: Their impact in diabetes-associated erectile dysfunction

Journal of Andrology

Volumn 25, Issue 5, 2004, Pages 830-836

  De Young, Ling ^a   Yu, Darryl ^a   Bateman, Ryon M ^b   Brock, Gerald B ^a,c  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

Impotence; Nitric oxide; Phosphodiesterase type 5; Sildenafil; Vitamin E

Indexed keywords

3 NITROTYROSINE; ALPHA ACTIN; ALPHA SMOOTH MUSCLE ACTIN; ALPHA TOCOPHEROL; ANTIOXIDANT; ARACHIS OIL; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PHOSPHODIESTERASE V; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; ERECTILE DYSFUNCTION; IMMUNOHISTOLOGY; INTRACAVERNOUS PRESSURE; MALE; NERVE STIMULATION; NONHUMAN; OXIDATIVE STRESS; PRESSURE; PRIORITY JOURNAL; RAT; SERUM; SMOOTH MUSCLE FIBER; STREPTOZOCIN DIABETES;

EID: 4143127859     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1939-4640.2004.tb02862.x     Document Type: Article

References (48)

1. Abderrahmane A, Salvail D, Dumoulin M, Garon J, Cadieux A, Rousseau E. Direct activation of K(Ca) channel in airway smooth muscle by nitric oxide: involvement of a nitrothiosylation mechanism? Am J Respir Cell Mol Biol. 1998;19:485-497.
2. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev. 1995;75:191-236.
3. Anggard EE. Endogenous and exogenous nitrates. Acta Anaesthesiol Scand Suppl. 1992;97:7-10.
4. Bateman RM, Ellis CG, Freeman DJ. Optimization of nitric oxide chemiluminescence operating conditions for measurement of plasma nitrite and nitrate. Clin Chem. 2002;48:570-573.
5. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48:1-9.
6. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271:C1424-C1437.
7. Benet AE, Melman A. The epidemiology of erectile dysfunction. Urol Clin North Am. 1995;22:699-709.
8. Blanco R, Saenz de Tejada I, Goldstein I, Krane RJ, Wotiz HH, Cohen RA. Dysfunctional penile cholinergic nerves in diabetic impotent men. J Urol. 1990;144:278-280.
9. Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V, Anglin G, Whitaker S. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168:1332-1336.
10. Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH. Nitric oxide: a physiologic mediator of penile erection. Science. 1992;257: 401-403.
11. Burton GW. Vitamin E: molecular and biological function. Proc Nutr Soc. 1994;53:251-262.
12. Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga C. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia. 2001;44:834-838.
13. Ceriello A, Quagliaro L, D'Amico M, et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes. 2002;51:1076-1082.
14. Cooke JP, Tsao PS. Cytoprotective effects of nitric oxide. Circulation. 1993;88:2451-2454.
15. De Young L, Yu D, Freeman D, Brock GB. Effect of PDE5 inhibition combined with free oxygen radical scavenger therapy on erectile function in a diabetic animal model. Int J Impot Res. 2003;15:347-354.
16. Escrig A, Marin R, Abreu P, Gonzalez-Mora JL, Mas M. Changes in mating behavior, erectile function, and nitric oxide levels in penile corpora cavernosa in streptozotocin-diabetic rats. Biol Reprod. 2002; 66:185-189.
17. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23:599-622.
18. Fries DM, Paxinou E, Themistocleous M, et al. Expression of inducible nitric-oxide synthase and intracellular protein tyrosine nitration in vascular smooth muscle cells: role of reactive oxygen species. J Biol Chem. 2003;278:22901-22907.
19. Goldstein I, Young JM, Fischer J, Bangerter K, Segerson T, Taylor T. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care. 2003;26: 777-783.
20. Gonzalez-Perez O, Gonzalez-Castaneda R, Huerta M, Luquin S, Gomez-Pinedo U, Sanchez-Almaraz E, Navarro-Ruiz A, Garcia-Estrada J. Beneficial effects of alpha-lipoic acid plus vitamin E on neurological deficit, reactive gliosis and neuronal remodeling in the penumbra of the ischemic rat brain. Neurosci Lett. 2002;321:100-104.
21. Hakim LS, Goldstein I. Diabetic sexual dysfunction. Endocrinol Metab Clin North Am. 1996;25:379-400.
22. Halcox JP, Nour KR, Zalos G, et al. The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. J Am Coll Cardiol. 2002;40:1232-1240.
23. Herman A, Adar R, Rubinstein Z. Vascular lesions associated with impotence in diabetic and nondiabetic arterial occlusive disease. Diabetes. 1978;27:975-981.
24. Hoeldtke RD, Bryner KD, McNeill DR, Hobbs GR, Baylis C. Peroxynitrite versus nitric oxide in early diabetes. Am J Hypertens. 2003;16: 761-766.
25. Islam KN, Devaraj S, Jialal I. alpha-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. Circulation. 1998;98:2255-2261.
26. Karasu C, Ozansoy G, Bozkurt O, Erdogan D, Omeroglu S. Antioxidant and triglyceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Antioxidants in Diabetes-Induced Complications (ADIC) Study Group. Metabolism. 1997;46:872-879.
27. Katusic ZS. Superoxide anion and endothelial regulation of arterial tone. Free Radical Biol Med. 1996;20:443-448.
28. Keegan A, Walbank H, Cotter MA, Cameron NE. Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia. 1995;38:1475-1478.
29. Kinlay S, Fang JC, Hikita H, et al. Plasma alpha-tocopherol and coronary endothelium-dependent vasodilator function. Circulation. 1999;100: 219-221.
30. Kolodny RC, Kahn CB, Goldstein HH, Barnett DM. Sexual dysfunction in diabetic men. Diabetes. 1974;23:306-309.
31. Lang D, Kredan MB, Moat SJ, Hussain SA, Powell CA, Bellamy MF, Powers HJ, Lewis MJ. Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: role for superoxide anions. Arterioscl Thromb Vasc Biol. 2000;20:422-427.
32. Maatman TJ, Montague DK, Martin LM. Erectile dysfunction in men with diabetes mellitus. Urology. 1987;29:589-592.
33. Mabile L, Bruckdorfer KR, Rice-Evans C. Moderate supplementation with natural alpha-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation. Atherosclerosis. 1999;147:177-185.
34. Mayes PA. Structure and function of the lipid-soluble vitamins. In: Murray RK, Granner DK, Mayes PA, Rodwell VW, eds. Harper's Biochemistry. 25th ed. Stamford, Conn: Appleton & Lange; 2000:642-652.
35. McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF. The prevalence of diabetic impotence. Diabetologia. 1980;18:279-283.
36. Mercuri F, Quagliaro L, Ceriello A. Oxidative stress evaluation in diabetes. Diabetes Technol Ther. 2000;2:589-600.
37. Moreland RB, Hsieh G, Nakane M, Brioni JD. The biochemical and neurologic basis for the treatment of male erectile dysfunction. J Pharmacol Exp Ther. 2001;296:225-234.
38. Park JY, Ha SW, King GL. The role of protein kinase C activation in the pathogenesis of diabetic vascular complications. Perit Dial Int. 1999; 19(suppl 2):S222-S227.
39. Pathania V, Syal N, Pathak CM, Khanduja KL. Changes in rat alveolar macrophageal antioxidant defense and reactive oxygen species release by high dietary vitamin E. J Nutr Sci Vitaminol (Tokyo). 1998;44: 491-502.
40. Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA. 1999;281:421-426.
41. Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med. 1989;320:1025-1030.
42. Saldeen T, Li D, Mehta JL. Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J Am Coll Cardiol. 1999;34:1208-1215.
43. Shite J, Qin F, Mao W, Kawai H, Stevens SY, Liang C. Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy. J Am Coll Cardiol. 2001;38:1734-1740.
44. Soriano FG, Pacher P, Mabley J, Liaudet L, Szabo C. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circ Res. 2001;89:684-691.
45. Tanaka S, Yashiro A, Nakashima Y, Nanri H, Ikeda M, Kuroiwa A. Plasma nitrite/nitrate level is inversely correlated with plasma low-density lipoprotein cholesterol level. Clin Cardiol. 1997;20:361-365.
46. Tesfamariam B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol. 1992;263:H321-H326.
47. van Haaften RL. Haenen GR, Evelo CT, Bast A. Effect of vitamin E on glutathione-dependent enzymes. Drug Metab Rev. 2003;35:215-253.
48. Willson RL. Free radical protection: why vitamin E, not vitamin C, beta-carotene or glutathione? Ciba Found Symp. 1983;101:19-44.